Back
Vertex Pharmaceuticals Vs. Gorman-Rupp Industry Stock Comparison
Buy
63
VRTX
Vertex Pharmaceuticals
Last Price:
402.50
Seasonality Move:
10.13%
Buy
66
GRC
Gorman-Rupp
Last Price:
32.80
Seasonality Move:
2.86%
Buy
63
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $401.08. The Score for VRTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Gorman-Rupp (GRC)
is a Buy
Is Gorman-Rupp a Buy, Sell or Hold?
- The current Gorman-Rupp [GRC] share price is $32.71. The Score for GRC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $401.08
The current trend is relatively stagnant and VRTX is experiencing slight selling pressure.
GRC Stock Price Chart
What is Gorman-Rupp's stock price today?
-
The Gorman-Rupp share price today is $32.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing slight buying pressure.
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.73 | Sell |
| Relative Strength Index (14 RSI): | 48.64 | Sell |
| Chaikin Money Flow: | -144131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (394.53 - 406.89) | Buy |
| Bollinger Bands (100): | (398.87 - 428.89) | Sell |
GRC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 33.29 | Sell |
| Chaikin Money Flow: | 19742 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.75 - 38.33) | Sell |
| Bollinger Bands (100): | (33.68 - 37.68) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 398.54 | Buy |
| 20-day SMA: | 398.43 | Buy |
| 50-day SMA: | 409.28 | Sell |
| 200-day SMA: | 384.62 | Buy |
| 8-day EMA: | 399.12 | Buy |
| 20-day EMA: | 400.55 | Buy |
| 50-day EMA: | 405.68 | Sell |
| 200-day EMA: | 386.45 | Buy |
GRC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.19 | Sell |
| 20-day SMA: | 35.41 | Sell |
| 50-day SMA: | 36.75 | Sell |
| 200-day SMA: | 33.57 | Sell |
| 8-day EMA: | 33.4 | Sell |
| 20-day EMA: | 34.88 | Sell |
| 50-day EMA: | 35.84 | Sell |
| 200-day EMA: | 33.66 | Sell |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.30 per share, an increase this year of $1.62 per share, and an increase next year of $1.37 per share.
Gorman-Rupp Earnings Growth & GRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.
Vertex Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gorman-Rupp Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||